Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-01
2010-02-16
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S471000
Reexamination Certificate
active
07662808
ABSTRACT:
This invention relates to novel diazabicyclic aryl derivatives which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemicals substances.
REFERENCES:
patent: 5478939 (1995-12-01), Trybulski et al.
patent: 6407095 (2002-06-01), Lochead et al.
patent: 6635645 (2003-10-01), Lochead et al.
patent: 7067507 (2006-06-01), Pulley et al.
patent: 2003/0114461 (2003-06-01), Galli et al.
patent: 2003/0153574 (2003-08-01), Galli et al.
patent: 2004/0029884 (2004-02-01), Gallet et al.
patent: 2004/0266757 (2004-12-01), Galli et al.
patent: 2005/0004258 (2005-01-01), Yamamoto et al.
patent: 2005/0020599 (2005-01-01), Galli et al.
patent: 1 219 622 (2002-07-01), None
patent: WO-99/42465 (1999-08-01), None
patent: WO-00/34279 (2000-06-01), None
patent: WO-00/34284 (2000-06-01), None
patent: WO-00/44755 (2000-08-01), None
patent: WO-01/92259 (2001-12-01), None
patent: WO-01/92260 (2001-12-01), None
patent: WO-01/92261 (2001-12-01), None
patent: WO-03/044019 (2003-05-01), None
patent: WO-03/044020 (2003-05-01), None
patent: WO-03/044024 (2003-05-01), None
patent: WO-2004/024729 (2004-03-01), None
patent: WO-2004/029053 (2004-04-01), None
Decker et al. Expert Opinion in Investigational Drugs, 2001, 10(10), 1819-1830.
“Biogenic amines”, http://www.nlm.nih.gov/cgi/mesh/2008/MB—cgi?mode=&index=14697&field=all&HM=&ll=&PA=&form=&input=, accessed Dec. 12, 2008, PDF attached.
“Receptors, Cholinergic”, http://www.nlm.nih.gov/cgi/mesh/2008/MB—cgi?mode=&index=11477&field=all&HM=&ll=&PA=&form=&input=, accessed Dec. 12, 2008.
“Central Nervous System Diseases”, http://www.nlm.nih.gov/cgi/mesh/2008/MB—cgi, accessed Dec. 12. 2008.
Wood et al. Expert Opinion in Investigational Drugs, 2002, 11(4), 457-67.
Jørgensen Tino Dyhring
Nielsen Elsebet Østergaard
Olsen Gunnar M.
Peters Dan
Timmermann Daniel B
Birch & Stewart Kolasch & Birch, LLP
Jarrell Noble
NeuroSearch A/S
Wilson James O
LandOfFree
Diazabicyclic aryl derivatives as cholinergic receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diazabicyclic aryl derivatives as cholinergic receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diazabicyclic aryl derivatives as cholinergic receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4208380